Literature DB >> 32585022

Genetics in the era of targeted CLL therapy.

Tatjana Stankovic1, Marwan Kwok1.   

Abstract

Mesh：

Substances：

Year:  2020        PMID： 32585022     DOI： 10.1182/blood.2020005595

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  1 in total

1.  The CADM1 tumor suppressor gene is a major candidate gene in MDS with deletion of the long arm of chromosome 11.

Authors:  Marina Lafage-Pochitaloff; Bastien Gerby; Véronique Baccini; Laetitia Largeaud; Vincent Fregona; Naïs Prade; Pierre-Yves Juvin; Laura Jamrog; Pierre Bories; Sylvie Hébrard; Stéphanie Lagarde; Véronique Mansat-De Mas; Oliver M Dovey; Kosuke Yusa; George S Vassiliou; Joop H Jansen; Tobias Tekath; David Rombaut; Geneviève Ameye; Carole Barin; Audrey Bidet; John Boudjarane; Marie-Agnès Collonge-Rame; Carine Gervais; Antoine Ittel; Christine Lefebvre; Isabelle Luquet; Lucienne Michaux; Nathalie Nadal; Hélène A Poirel; Isabelle Radford-Weiss; Bénédicte Ribourtout; Steven Richebourg; Stéphanie Struski; Christine Terré; Isabelle Tigaud; Dominique Penther; Virginie Eclache; Michaela Fontenay; Cyril Broccardo; Eric Delabesse
Journal:  Blood Adv       Date:  2022-01-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.